Braveheart Bio BRVE
$20.39 +$1.12 (+5.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.39 0.00%
Open$19.29
Prev close$19.27
Day range$18.83 – $21.16
Volume866.7K
Market cap$1.83B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts5
Average target$45.50+123.1% vs. price
- Buy 100%
Low $40.00Now $20.39Avg $45.50High $49.00
Recent rating changes
The last 13 actions on file set price targets from $40.00 to $49.00, averaging $44.83.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 11 Nov 2026 | Goldman Sachs | BUY | $49.00 |
| 9 Nov 2026 | Stifel | BUY | $45.00 |
| 7 Nov 2026 | Cantor Fitzgerald | BUY | $40.00 |
| 19 Oct 2026 | Cantor Fitzgerald | BUY | $40.00 |
| 1 Oct 2026 | Stifel | BUY | $45.00 |
| 9 Sep 2026 | Stifel | BUY | $45.00 |
| 8 Sep 2026 | Goldman Sachs | BUY | $48.00 |
| 6 Sep 2026 | Stifel | BUY | $45.00 |
| 31 Aug 2026 | TD Cowen | BUY | – |
| 31 Aug 2026 | Cantor Fitzgerald | BUY | $40.00 |
| 31 Aug 2026 | Jefferies | BUY | $48.00 |
| 31 Aug 2026 | Stifel | BUY | $45.00 |
| 31 Aug 2026 | Goldman Sachs | BUY | $48.00 |
No comments yet — be the first to weigh in on BRVE.
Sign in to join the discussion.